Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does OMEPRAZOLE Cause Hypercholesterolaemia? 53 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 53 reports of Hypercholesterolaemia have been filed in association with OMEPRAZOLE (omeprazole sodium bicarbonate). This represents 0.1% of all adverse event reports for OMEPRAZOLE.

53
Reports of Hypercholesterolaemia with OMEPRAZOLE
0.1%
of all OMEPRAZOLE reports
7
Deaths
26
Hospitalizations

How Dangerous Is Hypercholesterolaemia From OMEPRAZOLE?

Of the 53 reports, 7 (13.2%) resulted in death, 26 (49.1%) required hospitalization, and 4 (7.5%) were considered life-threatening.

Is Hypercholesterolaemia Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for OMEPRAZOLE. However, 53 reports have been filed with the FAERS database.

What Other Side Effects Does OMEPRAZOLE Cause?

Chronic kidney disease (35,759) Acute kidney injury (19,260) Renal failure (14,721) End stage renal disease (10,356) Renal injury (9,482) Tubulointerstitial nephritis (4,809) Drug ineffective (4,355) Gastrooesophageal reflux disease (3,929) Pain (3,602) Nephrogenic anaemia (2,873)

What Other Drugs Cause Hypercholesterolaemia?

ALENDRONATE (1,607) METHOTREXATE (1,547) TOCILIZUMAB (1,483) ADALIMUMAB (1,479) ABATACEPT (1,410) RITUXIMAB (1,389) PREDNISONE (1,377) INFLIXIMAB (1,338) DICLOFENAC (1,331) LEFLUNOMIDE (1,322)

Which OMEPRAZOLE Alternatives Have Lower Hypercholesterolaemia Risk?

OMEPRAZOLE vs OMEPRAZOLE\SODIUM BICARBONATE OMEPRAZOLE vs OMNIPAQUE OMEPRAZOLE vs OMNISCAN OMEPRAZOLE vs ONABOTULINUMTOXINA OMEPRAZOLE vs ONASEMNOGENE ABEPARVOVEC

Related Pages

OMEPRAZOLE Full Profile All Hypercholesterolaemia Reports All Drugs Causing Hypercholesterolaemia OMEPRAZOLE Demographics